SVRA · Savara Inc · Financials
$4.76
+0.13 (+2.81%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$951.28M
Shares
205.46M
Volume · Oct 20
4.42M
Avg daily vol (3M)
1.94M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$257K
FY2020
Net Income
-$118.84M
-23.9%
FY2025
Gross Margin
100%
FY2010
Operating Margin
-19182.88%
FY2020
Diluted EPS
-$0.53
-10.4%
FY2025
Operating Cash Flow
-$101.04M
-13.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 | FY2003 | FY2002 | FY2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | $257K | $0 | — | $0 | $400K | $54K | $0 | $0 | $0 | — | $488.96K | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $488.96K | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 100% | — | — | — | — | — | — | — | — | — | |
| $86.84M | $81.4M | $78.03M | $44.26M | $27.88M | $28.99M | $35.04M | $38.78M | $37.17M | $18.51M | $8.18M | $4.32M | $19.44M | $12.9M | $8.09M | $5.76M | $3.69M | — | — | — | — | — | — | — | — | — | |
| $56.71M | $42.06M | $25.04M | $15.67M | $10.93M | $12.35M | $14.26M | $13.08M | $10.65M | $11.08M | $2.82M | $1.65M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $8.09M | — | — | — | — | — | — | — | — | — | $9.34M | $10.96M | $9.49M | $8.52M | $7.52M | $7.19M | $4.99M | — | — | — | — | — | — | — | — | — | |
| $75K | $87K | $130K | $77K | $31K | $136K | $255K | $1.01M | $526K | — | $99K | $146K | $85K | $39.52K | $90.05K | $37.57K | $19.82K | — | — | — | — | — | — | — | — | — | |
| $143.63M | $123.55M | $103.2M | $60.01M | $38.84M | $41.48M | $49.56M | $79.03M | $70.05M | $29.96M | $11.35M | $5.98M | $29.28M | $21.54M | $15.63M | $13.4M | $9.03M | — | — | — | — | — | — | — | — | — | |
| -$143.63M | -$123.55M | -$103.2M | -$60.01M | -$38.84M | -$41.48M | -$49.3M | -$79.03M | -$70.05M | -$29.96M | -$10.95M | -$5.92M | -$29.28M | -$21.54M | -$15.63M | -$13.4M | -$8.54M | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | -19182.88% | — | — | — | -2737% | -10968.52% | — | — | — | — | -1746.51% | — | — | — | — | — | — | — | — | — | |
| -$143.55M | -$123.46M | -$103.07M | -$59.93M | -$38.81M | -$41.34M | -$49.05M | -$78.02M | -$69.52M | — | -$10.85M | -$5.78M | -$29.19M | -$21.5M | -$15.54M | -$13.36M | -$8.52M | — | — | — | — | — | — | — | — | — | |
| $617K | — | — | — | — | — | — | — | — | $1.16M | $452K | $2.59M | — | — | — | $11.01K | $1629 | — | — | — | — | — | — | — | — | — | |
| $94K | — | — | — | — | — | — | — | — | — | $122K | $130K | $69K | $60K | $73.56K | $65.58K | $92.87K | — | — | — | — | — | — | — | — | — | |
| $4.32M | $4.71M | $7.32M | $5.31M | $689K | -$1.54M | -$315K | $852K | $1.47M | -$3.48M | -$332K | -$3.08M | $508K | -$1000 | -$5047 | $71.38K | -$2469 | — | — | — | — | — | — | — | — | — | |
| — | -$118.84M | -$95.88M | -$54.7M | -$38.15M | -$43.01M | -$49.62M | -$78.17M | -$68.57M | -$33.43M | -$11.28M | -$9M | -$28.7M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $0 | $9000 | — | — | — | — | — | -$7.06M | -$3.63M | -$357K | $0 | $0 | $0 | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$139.31M | -$118.84M | -$95.88M | -$54.7M | -$38.15M | -$43.01M | -$49.62M | -$78.17M | -$61.52M | -$29.8M | -$10.92M | -$9M | -$28.7M | -$21.48M | -$15.56M | -$13.26M | -$8.45M | -$11.33M | -$26.65M | -$22.14M | -$29.33M | -$24.78M | -$6.7M | -$2.33M | -$2.11M | -$16.34M | |
| — | — | — | — | — | — | -19305.45% | — | — | — | -2730.75% | -16664.81% | — | — | — | — | -1728.35% | — | — | — | — | — | — | — | — | — | |
| -$139.31M | -$118.84M | -$95.88M | -$54.7M | -$38.15M | -$43.01M | -$49.62M | -$78.17M | -$61.52M | -$30.78M | -$11.02M | -$9.18M | — | -$21.48M | -$15.56M | -$13.26M | -$14.09M | — | — | — | — | — | — | — | — | — | |
| -$139.63M | -$118.17M | -$96.36M | -$54.36M | -$38.76M | -$43.95M | -$48.66M | -$78.39M | -$62.27M | -$28.25M | -$11.51M | -$9M | -$28.71M | -$21.5M | -$15.56M | -$13.26M | — | — | — | — | — | — | — | — | — | — | |
| USD/shares | -$0.58 | -$0.53 | -$0.48 | -$0.33 | -$0.25 | -$0.32 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | -$0.58 | -$0.53 | -$0.48 | -$0.33 | -$0.25 | -$0.32 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 222.39M | 198.19M | 165.2M | 152.77M | 133.92M | 59.31M | 40.03M | 33.3M | 17.52M | 1.96M | 968.81K | 122.41M | 76.59M | 47.64M | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 222.39M | 198.19M | 165.2M | 152.77M | 133.92M | 59.31M | 40.03M | 33.3M | 17.52M | 1.96M | 968.81K | 122.41M | 76.59M | 47.64M | — | — | — | — | — | — | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Showing the latest 26 of 29 periods — chart a line item for full history.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Long-term debt, including current maturities | 2026-06-30 | USD 30,109,000 | 10-Q filed 2026-08-11 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
| Operating lease liabilities | 2026-06-30 | USD 1,094,000 | 10-Q filed 2026-08-11 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 9.32×
EV/EBIT
—
Peer median 13.68×
P/E (TTM)
—
Peer median 12.56×
Peer medians compare against the 295 similar-size Biotechnology companies (of 559 listed).